These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24096218)
1. A comparative study of sexual dysfunction in schizophrenia patients taking aripiprazole versus risperidone. Shah SK Kathmandu Univ Med J (KUMJ); 2013; 11(42):121-5. PubMed ID: 24096218 [TBL] [Abstract][Full Text] [Related]
2. Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series. Chen CY; Lin TY; Wang CC; Shuai HA Psychiatry Clin Neurosci; 2011 Feb; 65(1):95-7. PubMed ID: 21265942 [TBL] [Abstract][Full Text] [Related]
3. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study. Jeong HG; Lee MS; Lee HY; Ko YH; Han C; Joe SH Int Clin Psychopharmacol; 2012 Jul; 27(4):177-83. PubMed ID: 22407277 [TBL] [Abstract][Full Text] [Related]
4. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). Hanssens L; L'Italien G; Loze JY; Marcus RN; Pans M; Kerselaers W BMC Psychiatry; 2008 Dec; 8():95. PubMed ID: 19102734 [TBL] [Abstract][Full Text] [Related]
5. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772 [TBL] [Abstract][Full Text] [Related]
6. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. Lu ML; Shen WW; Chen CH Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860 [TBL] [Abstract][Full Text] [Related]
7. The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone. Lee NY; Kim SH; Jung DC; Kim EY; Yu HY; Sung KH; Kang UG; Ahn YM; Kim YS Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1273-8. PubMed ID: 21513765 [TBL] [Abstract][Full Text] [Related]
8. [Aripiprazole for drug-induced sexual dysfunction in schizophrenic males]. Gao LJ; Guo HG; Liang ZT; Zhong XX; Zhu JC; Yang Y Zhonghua Nan Ke Xue; 2017 Jul; 23(7):615-619. PubMed ID: 29723454 [TBL] [Abstract][Full Text] [Related]
9. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia. Guirguis-Blake J Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753 [No Abstract] [Full Text] [Related]
10. Sexual dysfunction in schizophrenia: focus on recent evidence. Baggaley M Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766 [TBL] [Abstract][Full Text] [Related]
11. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone. Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial. Chan HY; Lin WW; Lin SK; Hwang TJ; Su TP; Chiang SC; Hwu HG J Clin Psychiatry; 2007 Jan; 68(1):29-36. PubMed ID: 17284127 [TBL] [Abstract][Full Text] [Related]
13. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. Yasui-Furukori N; Kaneda A; Sugawara N; Tomita T; Kaneko S J Psychopharmacol; 2012 Jun; 26(6):806-12. PubMed ID: 21616975 [TBL] [Abstract][Full Text] [Related]
14. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534 [TBL] [Abstract][Full Text] [Related]
15. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies. Janicak PG; Glick ID; Marder SR; Crandall DT; McQuade RD; Marcus RN; Eudicone JM; Assunção-Talbott S J Clin Psychiatry; 2009 Jan; 70(1):25-35. PubMed ID: 19192472 [TBL] [Abstract][Full Text] [Related]
16. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone. Lee SY; Park MH; Patkar AA; Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575 [TBL] [Abstract][Full Text] [Related]
18. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765 [TBL] [Abstract][Full Text] [Related]
19. Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy. Yeh YW Clin Neuropharmacol; 2011; 34(4):135-6. PubMed ID: 21768798 [TBL] [Abstract][Full Text] [Related]
20. A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). de Boer MK; Wiersma D; Bous J; Sytema S; van der Moolen AE; Wilffert B; Hamamura T; Knegtering H J Clin Psychopharmacol; 2011 Aug; 31(4):523-5. PubMed ID: 21720224 [No Abstract] [Full Text] [Related] [Next] [New Search]